Real-World data shows how breast cancer drug performs in indian patients
NCT ID NCT07363434
Summary
This study looked back at medical records to see how well the drug ribociclib, combined with standard hormone therapy, worked for Indian women with advanced breast cancer. It involved 335 women treated at 18 sites across India between 2018 and 2021. The goal was to understand the real-world effectiveness and safety of this treatment combination outside of a controlled clinical trial.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Novartis
East Hanover, New Jersey, 07936, United States
Conditions
Explore the condition pages connected to this study.